Meropenem EP impurity B | CAS 166901-45-7 - Request Quote

Meropenem EP impurity B is chemically (4R,5S,6S)-3-[[(3S,5S)-1-[(2S,3R)-2-[(2S,3R)-5-carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-3-methyl-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxybutanoyl]-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (as per EP) ; (4R,5S,6S)-3-{[(3S,5S)-1-{(2S,3R)-2-[(2S,3R)-5-Carboxy-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-3-methyl-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxybutanoyl}-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (as per USP). It is also known as Meropenem dimer (USP). Meropenem EP impurity B is supplied with detailed characterization data compliant with regulatory guideline. Meropenem EP impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Meropenem.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.